Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-14 · accession 0001062993-24-010536 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-16 | 2024-05-14 | COLL | BOHLIN GAREN G | Dir | M - OptEx | $5.73 | +29.0K | 73.8K | +65% | +$166.1K |
| D | 2024-05-16 | 2024-05-16 | COLL | BOHLIN GAREN G | Dir | A - Grant | $0.00 | +7,693 | 52.5K | +17% | $0 |
| D | 2024-05-16 | 2024-05-14 | COLL | BOHLIN GAREN G | Dir | S - Sale+OE | $32.30 | -29.0K | 44.8K | -39% | -$936.2K |
| D | 2024-05-16 | 2024-05-14 | COLL | BOHLIN GAREN G | Dir | M - OptEx | $0.00 | -29.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | M | A | 28,985 | $5.73 | 73,760 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-16 | A | A | 7,693 | $0.00 | 52,468 | D | — | — | (F2) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 16, 2025, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. |
| 3 | Common | Common Stock | 2024-05-14 | S | D | 28,985 | $32.30 | 44,775 | D | — | — | (F1) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Purchase) | 2024-05-14 | M | D | 28,985 | $0.00 | 0 | D | $5.73 · — to 2025-03-19 | 28,985 Common Stock | (F3) The option is fully vested and exercisable. |